[Is ophthalmologic screening essential during alpha interferon treatment?].
Emonet-Mercier
E
E
Touraud
J P
JP
Tsan
P
P
Chapard
J
J
Dalac
S
S
Lambert
D
D
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D012170:Retinal Vein Occlusion / Q000139:chemically induced*
D000970:Antineoplastic Agents; D016898:Interferon-alpha